The role of interferon in the thymus.


Journal

Current opinion in immunology
ISSN: 1879-0372
Titre abrégé: Curr Opin Immunol
Pays: England
ID NLM: 8900118

Informations de publication

Date de publication:
10 2023
Historique:
received: 23 03 2023
revised: 25 08 2023
accepted: 29 08 2023
pmc-release: 01 10 2024
medline: 2 10 2023
pubmed: 23 9 2023
entrez: 22 9 2023
Statut: ppublish

Résumé

Interferons (IFNs) are a family of proteins that are generated in response to viral infection and induce an antiviral response in many cell types. The COVID-19 pandemic revealed that patients with inborn errors of type-I IFN immunity were more prone to severe infections, but also found that many patients with severe COVID-19 had anti-IFN autoantibodies that led to acquired defects in type-I IFN immunity. These findings revealed the previously unappreciated finding that central immune tolerance to IFN is essential to immune health. Further evidence has also highlighted the importance of IFN within the thymus and its impact on T-cell development. This review will highlight what is known of IFN's role in T-cell development, T-cell central tolerance, and the impact of IFN on the thymus.

Identifiants

pubmed: 37738858
pii: S0952-7915(23)00108-5
doi: 10.1016/j.coi.2023.102389
pmc: PMC10543640
mid: NIHMS1929306
pii:
doi:

Substances chimiques

Interferons 9008-11-1
Interferon Type I 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

102389

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI035296
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI039560
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI039560
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Immunol. 2013 Apr 1;190(7):3289-98
pubmed: 23440417
Front Immunol. 2018 Mar 29;9:544
pubmed: 29651287
Virology. 2022 Feb;567:77-86
pubmed: 35032866
J Immunol. 2009 Sep 1;183(5):3229-36
pubmed: 19667093
Nat Rev Immunol. 2017 May;17(5):295-305
pubmed: 28317923
J Immunol. 2015 May 1;194(9):4265-76
pubmed: 25795758
J Exp Med. 2019 Nov 4;216(11):2466-2478
pubmed: 31434685
Nature. 1995 Feb 9;373(6514):531-6
pubmed: 7845467
J Allergy Clin Immunol. 2018 Apr;141(4):1479-1482.e6
pubmed: 29225085
Front Immunol. 2021 Apr 02;12:635569
pubmed: 33868260
J Autoimmun. 2020 Jan;106:102337
pubmed: 31594658
Ann Neurol. 2013 Feb;73(2):281-93
pubmed: 23280437
Nat Rev Immunol. 2005 Oct;5(10):772-82
pubmed: 16200080
Immunity. 2019 Sep 17;51(3):451-464.e6
pubmed: 31471108
Front Immunol. 2022 Oct 06;13:1009198
pubmed: 36275704
J Autoimmun. 2017 Jul;81:56-67
pubmed: 28385374
Front Immunol. 2017 Aug 16;8:976
pubmed: 28861084
Cell. 2022 Jul 7;185(14):2542-2558.e18
pubmed: 35714609
J Autoimmun. 2015 Dec;65:90-100
pubmed: 26385063
J Autoimmun. 2014 Aug;52:29-35
pubmed: 24440286
Nat Immunol. 2003 Apr;4(4):350-4
pubmed: 12612579
N Engl J Med. 1990 Jun 28;322(26):1829-36
pubmed: 2348835
J Clin Invest. 2015 Nov 2;125(11):4135-48
pubmed: 26457731
Immunity. 2015 Jun 16;42(6):1185-96
pubmed: 26084028
Nat Immunol. 2015 Sep;16(9):942-9
pubmed: 26237550
Sci Rep. 2013;3:1860
pubmed: 23681267
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Nat Commun. 2021 Sep 6;12(1):5303
pubmed: 34489451
Cell. 2016 Jul 28;166(3):582-595
pubmed: 27426947
Immunity. 2012 Jul 27;37(1):158-70
pubmed: 22705104
PLoS Pathog. 2018 Apr 19;14(4):e1006985
pubmed: 29672594
Cells. 2022 Apr 04;11(7):
pubmed: 35406782
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5420-5429
pubmed: 32094187
Immunity. 2016 Aug 16;45(2):305-18
pubmed: 27533013
Nat Immunol. 2016 May;17(5):565-73
pubmed: 27043411
J Autoimmun. 2014 Aug;52:44-52
pubmed: 24393484
J Exp Med. 2016 Nov 14;213(12):2527-2538
pubmed: 27821552
Science. 2020 Jan 17;367(6475):
pubmed: 31949051
PLoS Pathog. 2006 Jun;2(6):e62
pubmed: 16846255
Clin Exp Immunol. 2003 Apr;132(1):128-36
pubmed: 12653847
J Clin Invest. 2023 Feb 1;133(3):
pubmed: 36719370
Front Immunol. 2021 May 25;12:652538
pubmed: 34113341
Immunity. 2016 May 17;44(5):1102-13
pubmed: 27130899
Science. 2002 Nov 15;298(5597):1395-401
pubmed: 12376594
Blood. 2008 Oct 1;112(7):2657-66
pubmed: 18606876
Nature. 2018 Jul;559(7715):627-631
pubmed: 30022164
Sci Immunol. 2021 Aug 19;6(62):
pubmed: 34413139
Semin Immunol. 2019 Jun;43:101303
pubmed: 31771761
Proc Natl Acad Sci U S A. 2023 Feb 28;120(9):e2220120120
pubmed: 36802427
Nat Commun. 2021 Oct 18;12(1):6059
pubmed: 34663827
J Immunol. 2020 Sep 1;205(5):1268-1280
pubmed: 32690660

Auteurs

Ryan J Martinez (RJ)

Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota Medical School, University of Minnesota, Minneapolis, MN 55455, USA.

Kristin A Hogquist (KA)

Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota Medical School, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: hogqu001@umn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH